glp 1 agonist lilly Medscape Medscape | Orforglipron, Eli Lilly's

The result: a medication built on the same active pharmaceutical ingredient - semaglutide - but operating in a completely different regulatory category

These cases highlight the complexity of appetite regulation and the need for careful monitoring when using these medications

Safety Profile and Tolerability Concerns Gastrointestinal Adverse Effects While GLP-1RAs are effective in managing obesity, their use is associated with gastrointestinal side effects and rare but serious adverse events [42] [43] [44]

The relationship between GLP-1 and hair loss is complex and likely multifaceted, involving various factors that may contribute to hair shedding

Despite their potential side effects like delayed gastric emptying, pancreatitis, and GI symptoms warrant tailored regimens

doi: 10.1039/c8ra06697c 134 WangYZengZZhaoSTangLYanJLiNet al